Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
about
Asymmetric HIV-1 co-receptor use and replication in CD4(+) T lymphocytesThe soluble serum protein Gas6 bridges virion envelope phosphatidylserine to the TAM receptor tyrosine kinase Axl to mediate viral entrycis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptorPotential use of rapamycin in HIV infectionRole for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cellsFrequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switchHIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulationComprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virionsSynovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8HIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategiesRole of G protein-coupled receptors in control of dendritic cell migrationDendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?CD169-mediated trafficking of HIV to plasma membrane invaginations in dendritic cells attenuates efficacy of anti-gp120 broadly neutralizing antibodiesVaginal challenge with an SIV-based dual reporter system reveals that infection can occur throughout the upper and lower female reproductive tractKinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine familyAsymmetric deactivation of HIV-1 gp41 following fusion inhibitor bindingAccelerated immunodeficiency by anti-CCR5 treatment in HIV infectionAllosteric modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivityCellular superspreaders: an epidemiological perspective on HIV infection inside the bodyCD81 is an entry coreceptor for hepatitis C virusDefining the fitness of HIV-1 isolates with dual/mixed co-receptor usageCharacterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor.Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factorAn integrated stochastic model of "inside-out" integrin activation and selective T-lymphocyte recruitment.HIV Envelope gp120 Alters T Cell Receptor Mobilization in the Immunological Synapse of Uninfected CD4 T Cells and Augments T Cell ActivationPositron emission tomography imaging of tumors expressing the human chemokine receptor CXCR4 in mice with the use of 64Cu-AMD3100Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cellsConstitutive activation of CCR5 and CCR2 induced by conformational changes in the conserved TXP motif in transmembrane helix 2.Identification of CD4 and transferrin receptor antibodies by CXCR4 antibody-guided Pathfinder selection.Immune subversion by Mycobacterium tuberculosis through CCR5 mediated signaling: involvement of IL-10A microfluidic device for practical label-free CD4(+) T cell counting of HIV-infected subjects.Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kineticsHIV-1 infection of placental cord blood monocyte-derived dendritic cells.Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia.Preferential use of CXCR4 by R5X4 human immunodeficiency virus type 1 isolates for infection of primary lymphocytesBinding and transfer of human immunodeficiency virus by DC-SIGN+ cells in human rectal mucosa.Impact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys.Potent anti-R5 human immunodeficiency virus type 1 effects of a CCR5 antagonist, AK602/ONO4128/GW873140, in a novel human peripheral blood mononuclear cell nonobese diabetic-SCID, interleukin-2 receptor gamma-chain-knocked-out AIDS mouse model.Simian immunodeficiency virus utilizes human and sooty mangabey but not rhesus macaque STRL33 for efficient entry.Interaction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-adapted human immunodeficiency virus type 1 isolate
P2860
Q21245460-0E67E529-1AAB-46FB-A721-4F71141D2297Q24299966-13E7062A-B2A2-4174-A104-EF717915ED02Q24530658-46EC16ED-96EE-4FF8-BB02-21DA4B3B8E4EQ24606795-C30BA8B3-4C20-4547-B08C-369619E906E8Q24608200-BD3245A2-F221-4DC0-BFCE-028E80CDB4AAQ24672335-B93397F9-E2CF-4D37-804D-E97B2D21096DQ24676438-F56BB3E6-ADFF-4298-804F-EAC481C52E1FQ24678970-5AAF45C1-0051-43FE-B70F-9BA0F393FE50Q24793032-DAF3F33B-B470-449B-B320-8E1E881F0A29Q26825087-9BFAA8CD-D0FB-4D8E-B8B8-BFA7C29345FEQ26849785-D6DFFC46-7673-4E08-9E43-529C7085FA76Q27010312-800E8123-6E21-44A8-9958-B1F9AAF2627DQ27320842-2048ECC9-C937-4BCA-A4FD-C3E469E414A8Q27323310-81C7DD6A-7FB8-4620-82D9-1E7B3CBDA2A9Q28199376-F730ECFA-E7B1-43A3-98B1-2B34C1B7EAF3Q28471980-21E29FE9-B560-4529-924C-1CF33772899FQ28475890-FBD7D201-6551-4DD6-962F-BE7CD2978780Q28485983-58E11EF6-87D4-47F5-9F1D-E07267934FEEQ28657772-44FE6EE5-356A-4972-951C-52672B02D375Q29614812-8C830B8C-135A-4914-A5B4-3260B5B155F3Q30278577-F2A07A61-C92C-462E-8DE5-2597E555299FQ30378764-65ACD5EF-057E-414A-838A-46C26A38592CQ30448451-32D1C0AB-BE7D-4B5B-B8D6-88F9F9B9B188Q30504569-2F8185E3-35AC-4F0F-8279-9B5C838BC0B0Q30828739-EAF9526C-9606-44BB-B4F3-F53F6AE66677Q30836426-ACE339E6-9848-4D45-93B4-F48D6550AAEBQ30865013-A5E9B79E-57F3-410C-A21E-ABE12964AD0EQ30956674-7BE59580-9A32-47AB-91A3-8B649F974A47Q31026565-1230BE00-708F-4F0C-9D8D-1326F5AA90EEQ31155201-EB9D7566-209E-4057-892D-91A524ACA00BQ33271334-3C1CD1BE-DB00-4949-B5AA-AEF395794122Q33429049-BA93C006-63FE-4045-8C75-E97F3F14B7CAQ33564810-17903062-098B-40A8-B94A-9DFA90BD03DBQ33708995-4578A23E-EE65-4125-B80C-FE98AE97CA0CQ33716586-7602C954-09B7-4D09-81FC-BC1E1E291643Q33754936-565E7BD4-5FC6-4996-A6EF-62169973D7EFQ33780668-FF08B7D2-443C-4C13-A17F-E5222F2F4160Q33781391-2DF591D2-673D-48DB-A641-43DB28D1887CQ33787066-83E7C76C-4B58-4772-B632-25A1743CDE9AQ33788874-BAC3C615-44C0-4748-B453-02F19608BF31
P2860
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Quantification of CD4, CCR5, a ...... d monocyte-derived macrophages
@ast
Quantification of CD4, CCR5, a ...... d monocyte-derived macrophages
@en
type
label
Quantification of CD4, CCR5, a ...... d monocyte-derived macrophages
@ast
Quantification of CD4, CCR5, a ...... d monocyte-derived macrophages
@en
prefLabel
Quantification of CD4, CCR5, a ...... d monocyte-derived macrophages
@ast
Quantification of CD4, CCR5, a ...... d monocyte-derived macrophages
@en
P2093
P2860
P356
P1476
Quantification of CD4, CCR5, a ...... d monocyte-derived macrophages
@en
P2093
D Weissman
L J Montaner
P2860
P304
P356
10.1073/PNAS.96.9.5215
P407
P50
P577
1999-04-01T00:00:00Z